急性等容血液稀释减少开放腹主动脉瘤修复输血需求
研究回顾性比较2017-2019年开放腹主动脉瘤修复中使用急性等容血液稀释(ANH)与仅按指征输注血制品的患者,ANH组围术期及住院期间红细胞输注更少,凝血指标更优,住院时间更短。
要点
- ANH可减少开放腹主动脉瘤修复术中和术后红细胞输注需求。
- ANH组48小时血小板计数更高、部分凝血活酶时间和INR更低。
- ANH组住院时间更短,心肌梗死、再手术和死亡率无差异。
核心结论
- 开放腹主动脉瘤修复中使用ANH可减少围术期和术后红细胞输注,改善凝血参数并缩短住院时间。
研究设计与样本
- 回顾性研究,纳入2017至2019年在一家四级主动脉转诊中心行择期开放腹主动脉瘤修复且符合ANH条件的76例患者。
临床怎么用
- 对符合ANH条件(无活动性心肌缺血、无瓣膜病、左右心室功能正常、慢性肾病分期<3、血细胞比容>38%、凝血功能正常)的择期开放腹主动脉瘤修复患者,可考虑使用ANH以减少红细胞输注。
局限性
- 回顾性研究,样本量较小,仅纳入符合ANH条件的患者,结果可能不适用于所有开放腹主动脉瘤修复人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Acute normovolemic hemodilution (ANH) is an operative blood conservation technique involving the removal and storage of patient blood after the induction of anesthesia, with maintenance of normovolemia by crystalloid and/or colloid replacement. Developed and used predominately in cardiac surgery, ANH has been applied to the vascular surgery population. However, data regarding the effects on transfusion requirements in this population are limited. The objective of the present study was to compare the transfusion requirements and coagulopathy for patients who had undergone open abdominal aortic aneurysm repair (oAAAR) using ANH to those for patients who had received only product replacements, as clinically indicated. METHODS: We performed a retrospective review of patients who had undergone elective oAAAR at a quaternary aortic referral center from 2017 to 2019. Those eligible for ANH, with no active cardiac ischemia, no valvular disease, normal left ventricular and right ventricular function, chronic kidney disease stage <3, hematocrit >38%, and a normal coagulation profile were included in the present study. Patient demographics and characteristics and operative variables, including aneurysm extent, clamp site, visceral and renal ischemia time, operative time, and transfusion requirements, were collected. Postoperative morbidity, mortality, and length of stay were analyzed. The patients with and without ANH were matched and compared. Continuous measures were analyzed using Wilcoxon rank sum tests and t tests. RESULTS: During the study period, 209 oAAARs had been performed. Of the 209 patients, 76 had met the inclusion criteria. Of these 76 patients, 27 had undergone ANH and 49 had not. The patients with ANH had required fewer PRBC transfusions intraoperatively (median, 0 U; interquartile range [IQR], 0-1 U; median, 1 U; IQR, 0-2 U; P = .02), at 24 hours (median, 0 U; IQR, 0-1 U; vs median, 1 U; IQR, 0-2 U; P = .008), at 48 hours (median, 0 U; IQR, 0-1 U; vs median, 1 U; IQR, 0-2; P = .007), and throughout the admission (median, 0 U; IQR, 0-1 U; vs median, 2 U; IQR, 0-2 U; P = .011). No difference was found in the number of intraoperative platelet or cryoprecipitate transfusions. At 48 hours, the ANH group had had significantly greater platelet counts (142 ± 35.8 × 103/μL vs 124 ± 37.6 × 103/μL; P = .044), lower partial thromboplastin time, and lower international normalized ratio. No difference in myocardial infarction, return to the operating room, or mortality (one death overall). The ANH patients had a shorter length of stay (7.0 ± 2.7 vs 8.8 ± 4.8 days; P = .041). CONCLUSIONS: The use of ANH during oAAAR resulted in fewer intraoperative and postoperative PRBC transfusions with improved coagulation parameters and a shorter hospital length of stay.
引用
- Droz NM, Lin J, Beach J, et al. Decreased transfusion requirements with use of acute normovolemic hemodilution in open aortic aneurysm repair. J Vasc Surg. 2021. PMID: 34082004. doi:10.1016/j.jvs.2021.05.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。